Wonvas-F Tablet
Images are for reference. Actual packaging may vary.
Strip of 15 tablets • TabletPrescription requiredSchedule H
Wonvas-F Tablet
Fenofibrate (160mg) + Rosuvastatin (10mg)
₹199.00
Strip of 15 tablets • Tablet
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Rosuvastatin 10 mg
+1 more active ingredient
How It Works
Rosuvastatin inhibits HMG-CoA reductase, decreasing cholesterol synthesis in the liver and increasing LDL receptor expression.
Fenofibrate activates peroxisome proliferator-activated receptor alpha (PPAR-alpha), enhancing lipid metabolism and reducing triglyceride levels.
Medicine Strength
10 mg
All Active Ingredients
Rosuvastatin10 mg
Fenofibrate160 mg
Uses & Benefits
Medical applications
Cholesterol
Wonvas-F Tablet is a combination medication containing Fenofibrate 160 mg and Rosuvastatin 10 mg, indicated for the management of dyslipidemia and mixed hyperlipidemia. Fenofibrate, a fibric acid derivative, primarily acts by activating peroxisome proliferator-activated receptor alpha (PPARα), which enhances lipolysis and elimination of triglyceride-rich particles, thereby reducing serum triglycerides and increasing high-density lipoprotein cholesterol (HDL-C).
Read full descriptionShow less
Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) by inhibiting the rate-limiting enzyme in cholesterol biosynthesis. The combination therapy offers a synergistic effect in improving lipid profiles, reducing total cholesterol, LDL-C, triglycerides, and increasing HDL-C levels, thus aiding in the prevention of cardiovascular events in patients with mixed dyslipidemia who require multiple lipid-lowering agents.
Wonvas-F is typically prescribed as an adjunct to diet and lifestyle modifications, including exercise and weight control. It is contraindicated in patients with active liver disease, severe renal impairment, or hypersensitivity to its components. Regular monitoring of liver function tests, renal parameters, and lipid levels is recommended during therapy. Caution should be exercised to avoid potential adverse effects such as myopathy and hepatotoxicity.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
Customer Reviews
0 reviews for Wonvas-F Tablet
